FORTIS

Fortis Healthcare Limited

Multi-specialty hospital network, plus Agilus diagnostics

Healthcare›Healthcare›Healthcare Services›Hospital

fortishealthcare.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹736.50
Market cap
55,580 Cr
Stock P/E
53.0
P/B
5.62
Dividend yield
0.1%
ROE (FY26)
10.2%
ROCE (FY26)
12.9%
Operating margin (FY26)
17.9%
Debt / equity (FY26)
0.29
OCF / EBITDA (FY26)
76.8%
OCF / EBITDA (3Y)
83.5%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Fortis (Fortis Healthcare) runs a network of multi-specialty hospitals in India and, through its subsidiary Agilus Diagnostics, a diagnostics testing business.

Company snapshot

5thBy market cap

Ranked among 24 companies in Hospital.

Segment mix

Reportable segments as of 2024-12-31 (Consolidated). Revenue share = segment revenue ÷ total revenue.

Largest segment: 84.2% of revenue

SegmentRevenue shareRevenuePBTAssets
Diagnostic
17.8%
342 Cr21 Cr2,120 Cr
Healthcare
84.2%
1,623 Cr257 Cr9,811 Cr
Intersegment—0 Cr0 Cr-32 Cr

Shares add up to 102% because segment revenues are before inter-segment eliminations.

What we see

Positives
  • ✓Debt-to-equity of 0.29x — the company is largely funded by its own money, not borrowed funds.

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales1,770 Cr1,680 Cr1,786 Cr1,859 Cr1,988 Cr1,928 Cr2,007 Cr2,167 Cr2,331 Cr2,265 Cr2,365 Cr2,545 Cr
Operating expenses (approx.)1,440 Cr1,396 Cr1,405 Cr1,516 Cr1,554 Cr1,553 Cr1,572 Cr1,676 Cr1,775 Cr1,759 Cr1,832 Cr2,008 Cr
EBITDA330 Cr284 Cr381 Cr343 Cr435 Cr375 Cr435 Cr491 Cr556 Cr506 Cr532 Cr537 Cr
OPM %18.7%16.9%21.3%18.4%21.9%19.5%21.7%22.6%23.9%22.3%22.5%21.1%
Other income14 Cr7 Cr10 Cr13 Cr13 Cr21 Cr20 Cr15 Cr23 Cr8 Cr4 Cr14 Cr
Interest32 Cr33 Cr35 Cr35 Cr36 Cr45 Cr68 Cr70 Cr75 Cr86 Cr84 Cr80 Cr
Depreciation84 Cr87 Cr92 Cr91 Cr95 Cr97 Cr102 Cr101 Cr106 Cr120 Cr122 Cr122 Cr
Profit before tax233 Cr183 Cr271 Cr230 Cr261 Cr279 Cr237 Cr351 Cr425 Cr266 Cr324 Cr363 Cr
Tax %21.0%26.7%25.1%24.4%26.0%9.0%20.5%23.9%22.7%25.7%16.4%24.9%
Net profit184 Cr134 Cr203 Cr174 Cr193 Cr254 Cr188 Cr267 Cr329 Cr197 Cr271 Cr273 Cr
EPS (₹)₹2.30₹1.78₹2.37₹2.20₹2.34₹3.28₹2.44₹3.45₹4.26₹2.57₹3.52₹3.53

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales4,574 Cr4,561 Cr4,469 Cr4,632 Cr4,030 Cr5,718 Cr6,298 Cr6,893 Cr7,783 Cr9,128 CrSign in free for the trailing twelve months
Operating expenses (approx.)4,221 Cr4,288 Cr4,244 Cr4,023 Cr3,626 Cr4,649 Cr5,196 Cr5,625 Cr6,195 Cr7,043 CrSign in free for the trailing twelve months
EBITDA353 Cr273 Cr225 Cr610 Cr404 Cr1,069 Cr1,101 Cr1,268 Cr1,588 Cr2,085 CrSign in free for the trailing twelve months
OPM %7.7%6.0%5.0%13.2%10.0%18.7%17.5%18.4%20.4%22.8%Sign in free for the trailing twelve months
Other income166 Cr140 Cr92 Cr53 Cr47 Cr27 Cr62 Cr38 Cr67 Cr51 CrSign in free for the trailing twelve months
Interest229 Cr258 Cr337 Cr205 Cr166 Cr147 Cr129 Cr131 Cr184 Cr314 CrSign in free for the trailing twelve months
Depreciation222 Cr239 Cr233 Cr292 Cr291 Cr301 Cr316 Cr343 Cr386 Cr449 CrSign in free for the trailing twelve months
Profit before tax552 Cr-912 Cr-110 Cr239 Cr43 Cr988 Cr814 Cr858 Cr1,007 Cr1,366 CrSign in free for the trailing twelve months
Tax %13.1%-2.5%-103.2%61.8%229.8%20.0%22.2%24.8%19.6%22.1%Sign in free for the trailing twelve months
Net profit479 Cr-934 Cr-224 Cr91 Cr-56 Cr790 Cr633 Cr645 Cr809 Cr1,064 CrSign in free for the trailing twelve months
EPS (₹)₹8.87₹-19.46₹-3.70₹0.77₹-1.45₹7.35₹7.80₹7.93₹10.26₹13.80Sign in free for the trailing twelve months
Dividend payout %—————0.0%2.5%13.3%13.5%7.3%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital518 Cr519 Cr755 Cr755 Cr755 Cr755 Cr755 Cr755 Cr755 Cr755 Cr
Reserves4,626 Cr3,543 Cr5,846 Cr5,906 Cr5,365 Cr5,423 Cr6,487 Cr6,908 Cr8,162 Cr9,141 Cr
Borrowings1,959 Cr1,400 Cr1,868 Cr1,529 Cr1,407 Cr1,255 Cr926 Cr858 Cr2,475 Cr2,873 Cr
Other liabilities1,447 Cr1,904 Cr2,971 Cr2,613 Cr3,030 Cr3,622 Cr3,407 Cr3,874 Cr2,047 Cr2,925 Cr
Total liabilities9,717 Cr8,622 Cr11,951 Cr11,348 Cr11,155 Cr11,885 Cr12,434 Cr13,289 Cr13,692 Cr15,966 Cr
Fixed assets (net)2,974 Cr2,849 Cr4,694 Cr5,021 Cr5,015 Cr4,950 Cr4,850 Cr5,268 Cr5,848 Cr5,348 Cr
CWIP235 Cr194 Cr421 Cr189 Cr163 Cr193 Cr228 Cr540 Cr404 Cr432 Cr
Investments1,878 Cr1,732 Cr270 Cr175 Cr186 Cr104 Cr210 Cr230 Cr169 Cr1,782 Cr
Loans & advances———17 Cr14 Cr1 Cr2 Cr2 Cr2 Cr2 Cr
Inventories62 Cr67 Cr57 Cr78 Cr77 Cr123 Cr123 Cr107 Cr115 Cr135 Cr
Trade receivables473 Cr470 Cr542 Cr459 Cr390 Cr512 Cr582 Cr628 Cr784 Cr1,044 Cr
Cash & bank544 Cr130 Cr794 Cr182 Cr261 Cr143 Cr141 Cr235 Cr140 Cr407 Cr
Other assets3,551 Cr3,180 Cr5,174 Cr5,228 Cr5,049 Cr5,858 Cr6,299 Cr6,279 Cr6,229 Cr6,815 Cr
Total assets9,717 Cr8,622 Cr11,951 Cr11,348 Cr11,155 Cr11,885 Cr12,434 Cr13,289 Cr13,692 Cr15,966 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity966 Cr554 Cr—172 Cr486 Cr865 Cr822 Cr1,100 Cr1,424 Cr1,602 Cr
Cash from investing-1,002 Cr-333 Cr—60 Cr-135 Cr-514 Cr-374 Cr-886 Cr-779 Cr-1,538 Cr
Cash from financing259 Cr-733 Cr—-862 Cr-143 Cr-517 Cr-471 Cr-86 Cr-714 Cr164 Cr
Net cash flow224 Cr-513 Cr—-627 Cr212 Cr-166 Cr-21 Cr125 Cr-70 Cr228 Cr
Free cash flow (OCF − Capex)689 Cr373 Cr—16 Cr267 Cr650 Cr375 Cr158 Cr577 Cr656 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %9.4%-9.7%2.5%5.1%2.6%13.7%10.4%10.5%10.2%12.9%
ROE %6.7%-19.0%-3.1%1.1%-1.6%7.9%7.3%7.0%8.4%10.2%
Debtor days38384436353334333742
Inventory days52422302987655
Days payable472852952262044241393838
Cash conversion cycle-4-223-229-161-141-2-1049
OCF / EBITDA %273.9%202.7%—28.1%120.0%81.0%74.7%86.8%89.7%76.8%
OCF / EBITDA % (3 years)—————73.1%84.4%81.1%84.6%83.5%
Debt / equity0.380.340.280.230.230.200.130.110.280.29
Current ratio0.920.600.460.621.251.321.390.691.350.86
Net debt / EBITDA4.01——2.212.831.040.710.491.471.18